0 items USD 0.00Search
Your search for "global markets direct epithelial ovarian cancer pipeline review h1 2016" gave back 322 results.
This report provides you with a landscape description and analysis of discovery and development of claudin 18.2 (CLDN18.2)-targeted antibody and cell...
Catalog:
La Merie Publishing
August 2023
Price: USD 2,365.00
There is an emerging trend towards precision health in today’s world to enhance disease diagnosis, treatment, prevention and monitoring by using...
Catalog:
IQ4I
February 2020
Price: USD 4,950.00
Claudin 6 (CLDN6) is a compelling tumor antigen. The tetraspan membrane protein is a member of the claudin family of tight junction proteins. CLDN6...
Catalog:
La Merie Publishing
May 2022
Price: USD 560.00
“Lutetium-177 Global Market Analysis” gives comprehensive insights on the various Lu-177 based drugs being developed for the treatment of GEP-NET,...
IQ4I
February 2020
Price: USD 3,600.00
The understanding of the pathways of cancer development and their causes has led to the development of novel methodologies, and there is an emerging...
Catalog:
IQ4I
June 2020
Price: USD 4,950.00
Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players Summary GBI Research’s latest report,...
Catalog:
CBR Pharma Insights
October 2018
Price: USD 2,995.00
Report Package: Bispecific Antibodies This report package includes the full report T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: a...
Catalog:
La Merie Publishing
July 2019
Price: USD 2,840.00
The report entitled „Antibody-Drug Conjugates 2014 – A Business, Technology & Pipeline Analysis“ published in January 2014 is based on the...
Catalog:
La Merie Publishing
January 2014
Price: USD 2,298.00
Global Clinical Trials - Current Trends and Recent Advancement Summary GBI Research’s latest report, Global Clinical Trials - Current Trends and...
Catalog:
CBR Pharma Insights
January 2019
Price: USD 2,995.00
This report evaluates G-protein–coupled receptor family C group 5 member D (GPRC5D) from an industry perspective for its suitability as a tumor-...
Catalog:
La Merie Publishing
July 2022
Price: USD 670.00
T-Cell & NK-Cell Engaging Bispecific Antibo dies 2019: a business, stakeholder, technology and pipeline analysis report provides you with a...
Catalog:
La Merie Publishing
June 2019
Price: USD 2,700.00
The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players Summary GBI Research’s latest...
Catalog:
CBR Pharma Insights
May 2018
Price: USD 2,995.00
This report provides a landscape description and analysis of chimeric antigen receptor-macrophage (CAR-M) platform technologies and stakeholders from...
Catalog:
La Merie Publishing
February 2023
Price: USD 2,000.00
Innovation Tracking Factbook 2018: An Assessment of the Pharmaceutical Pipeline Summary GBI Research’s latest report “Innovation Tracking Factbook...
Catalog:
CBR Pharma Insights
December 2018
Price: USD 2,995.00
Emerging Gene Therapies - Trends within the Technological, Clinical, Regulatory and Competitive Landscape Summary GBI Research’s latest report “...
Catalog:
CBR Pharma Insights
January 2019
Price: USD 2,995.00
